Tuesday, October 26, 2021 12:24 AM
LAVAL, QC and ALPHARETTA, Ga.—Bausch + Lomb
, a global eye health business of Bausch Health Companies Inc. (NYSE/TSX: BHC) and Clearside Biomedical, Inc.
(Nasdaq: CLSD) announced Monday that the U.S. Food and Drug Administration (FDA) has approved the drug Xipere (triamcinolone acetonide injectable suspension) for suprachoroidal use for the treatment of macular edema associated with uveitis, a form of eye inflammation. "With this FDA approval, Xipere is the first and only therapy available in the United States that utilizes the suprachoroidal space to treat patients suffering from macular edema associated with uveitis, which is the leading cause of vision loss in people with uveitis," said Joseph C. Papa, chairman and CEO, Bausch Health.
Tuesday, October 26, 2021 12:21 AM
SEATTLE, Wash.—Kubota Vision Inc.
, a clinical-stage specialty ophthalmology company and a wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), announced that the company received Quality Management System - ISO 13485:2016 certification for the design and development of ophthalmic medical devices.
Tuesday, October 26, 2021 12:18 AM
MIAMI—Bascom Palmer Eye Institute
of the University of Miami Miller School of Medicine
announced that Christopher J. Kaler has received a Research to Prevent Blindness (RPB) Medical Student Eye Research Fellowship that will allow him to take a year off from medical school and to devote that time to pursue a research project at Bascom Palmer.
Tuesday, October 26, 2021 12:15 AM
NEW YORK—Vision Monday
and 20/20 Magazine
are teaming up for the 13th annual EyeVote Readers' Choice Awards to identify
the optical industry’s favorite products and companies this year.
Monday, October 25, 2021 12:30 AM
NEW YORK—Escalated by the pandemic, consumers and patients are demonstrating their openness to using new technologies to redefine their own sense of wellness and take care of their own health. This is furthering the advent of new remote monitoring systems and wearables which are directly involving the patient in managing care with their doctors. Experts discussed these "Remote Possibilities" during VM's virtual Leadership Summit last week. They talked about how these technology developments can actually strengthen provider relationships with patients and provide healthier outcomes, too.
Monday, October 25, 2021 12:27 AM
SAN DIEGO—Reflecting the partnership between Shamir
and the Alpine Formula 1 team, a unique optical technology collaboration announced earlier this year, as VMAIL reported
, Shamir took further steps late last week to share more information about their collaboration which will be leading up to the launch in early December this year.
Monday, October 25, 2021 12:24 AM
PINELLAS PARK, Fla.—Transitions Optical
is hosting an online educational event for industry professionals on Tuesday, November 9.
Monday, October 25, 2021 12:21 AM
TAIBON AGORDINO, Italy—On October 13, Blackfin
celebrated its 50th anniversary with the opening of its new Black Shelter headquarters, a building that nearly triples the space in its existing Taibon Agordino location, surrounded by the Belluno Dolomite mountains.
Monday, October 25, 2021 12:18 AM
ORLANDO, Fla.—The American Academy of Optometry Foundation
(AAOF) in collaboration with the Beta Sigma Kappa International Optometric Honor Society announced that Kevin Willeford, OD, MS, PhD, FAAO, has been named as the 2021 recipient of the Beta Sigma Kappa (BSK) Research Fellowship. Dr. Willeford is an associate professor at the Nova Southeastern University College of Optometry. This fellowship is designed to provide support for early career optometric and vision science faculty research. It will fund Dr. Willeford’s project, “Do non-strabismic individuals use slow fusional vergence to stabilize binocular alignment across gaze positions?”
Monday, October 25, 2021 12:15 AM
RANDOLPH, Mass.—Stanley Zaleski, co-founder of Randolph Engineering
, passed away peacefully on Oct. 16, 2021 at the age of 82. Stanley immigrated to the U.S. from Poland at the age of 19. He attended Wentworth Institute of Technology where he earned a degree in Mechanical Engineering. Soon after graduating, Zaleski was drafted to service for active duty in the U.S. Army from 1961 to 1963 and continued to serve in the Army Reserves until 1967.
Friday, October 22, 2021 12:33 AM
NEW YORK—As the Oct. 20 virtual VM Leadership Summit kicked off on Wednesday afternoon, two expert speakers talked about how the pandemic has put patients' trust to the test, and more importantly, how providers can tackle the issue of misinformation and help counter the formidable challenge of rebuilding that trust. In a session titled Rebuilding Trust, Dr. John Whyte, chief medical officer for WebMD
and Jennifer Hauser, head of Edelman’s Wellness 360
business unit, shared views about how today’s eyecare professionals can build trust with their patients.
Friday, October 22, 2021 12:30 AM
NORWALK, Conn.—Returning to a live, in-person format for 2022, IDOC’s
annual national conference, The Connection, is scheduled for Feb. 24-26 in Orlando, Fla.
Friday, October 22, 2021 12:27 AM
announces the creation of a state-of-the-art digital event platform, the Essilor Vision Care Center, and opens registration for the center’s inaugural event: the Global Varilux Summit.
Friday, October 22, 2021 12:24 AM
DULUTH, Ga.—National Vision, Inc.
(NASDAQ: EYE) released its first Corporate Responsibility Report, titled A World Worth Seeing
as part of its ongoing efforts to increase transparency in its environmental, social and governance (ESG) activities.
Friday, October 22, 2021 12:21 AM
SEATTLE, BOSTON and TOKYO—Aurion Biotech
, which is developing novel treatments for preventing blindness, has formed a medical advisory board composed of eminent ophthalmologists. The board will collaborate with the company’s executive team in clinical development, and is chaired by Edward Holland, MD, who was recently appointed as Aurion Biotech's chief medical advisor. “The doctors on this board are among the best in our field,” said Dr. Holland. “Their expertise, commitment to, and enthusiasm for Aurion Biotech’s cell therapy speak volumes about the transformational potential of this treatment to cure blindness resulting from corneal endothelial disease. I welcome their contributions. It’s a privilege to work closely with each of them.”